Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Patchett

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimeticsB L Palucki, S D Feighner, S Pong, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Hormone Research|December 11, 1999
Growth hormone releasing substances: types and their receptorsR G Smith, O C Palyha, S D Feighner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagoguesK J Barakat, K Cheng, W W Chan, et al.
Science (New York, N.Y.)|November 8, 1996
Antibacterial agents that inhibit lipid A biosynthesisH R Onishi, B A Pelak, L S Gerckens, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonistsC Zhou, L Guo, G Morriello, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclizationA Pasternak, Y Pan, D Marino, et al.
Molecular Endocrinology (Baltimore, Md.)|January 11, 2000
Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from Pufferfish to humansO C Palyha, S D Feighner, C P Tan, et al.
Molecular Endocrinology (Baltimore, Md.)|January 24, 1998
Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagoguesS D Feighner, A D Howard, K Prendergast, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimeticsB L Palucki, S D Feighner, S Pong, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Hormone Research|December 11, 1999
Growth hormone releasing substances: types and their receptorsR G Smith, O C Palyha, S D Feighner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagoguesK J Barakat, K Cheng, W W Chan, et al.
Science (New York, N.Y.)|November 8, 1996
Antibacterial agents that inhibit lipid A biosynthesisH R Onishi, B A Pelak, L S Gerckens, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonistsC Zhou, L Guo, G Morriello, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 1999
Potent, orally bioavailable somatostatin agonists: good absorption achieved by urea backbone cyclizationA Pasternak, Y Pan, D Marino, et al.
Molecular Endocrinology (Baltimore, Md.)|January 11, 2000
Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from Pufferfish to humansO C Palyha, S D Feighner, C P Tan, et al.
Molecular Endocrinology (Baltimore, Md.)|January 24, 1998
Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagoguesS D Feighner, A D Howard, K Prendergast, et al.
Pageof 7